Literature DB >> 31069800

How is alpha-synuclein cleared from the cell?

Leonidas Stefanis1,2, Evangelia Emmanouilidou1, Marina Pantazopoulou1, Deniz Kirik3, Kostas Vekrellis1, George K Tofaris4.   

Abstract

The levels and conformers of alpha-synuclein are critical in the pathogenesis of Parkinson's Disease and related synucleinopathies. Homeostatic mechanisms in protein degradation and secretion have been identified as regulators of alpha-synuclein at different stages of its intracellular trafficking and transcellular propagation. Here we review pathways involved in the removal of various forms of alpha-synuclein from both the intracellular and extracellular environment. Proteasomes and lysosomes are likely to play complementary roles in the removal of intracellular alpha-synuclein species, in a manner that depends on alpha-synuclein post-translational modifications. Extracellular alpha-synuclein is cleared by extracellular proteolytic enzymes, or taken up by neighboring cells, especially microglia and astrocytes, and degraded within lysosomes. Exosomes, on the other hand, represent a vehicle for egress of excess burden of the intracellular protein, potentially contributing to the transfer of alpha-synuclein between cells. Dysfunction in any one of these clearance mechanisms, or a combination thereof, may be involved in the initiation or progression of Parkinson's disease, whereas targeting these pathways may offer an opportunity for therapeutic intervention. This article is part of the Special Issue "Synuclein".
© 2019 International Society for Neurochemistry.

Entities:  

Keywords:  alpha-synuclein; degradation; exosomes; lysosomes; proteasome; ubiquitin

Mesh:

Substances:

Year:  2019        PMID: 31069800     DOI: 10.1111/jnc.14704

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  49 in total

1.  Antioxidants and Neuron-Astrocyte Interplay in Brain Physiology: Melatonin, a Neighbor to Rely on.

Authors:  Antonio Gonzalez
Journal:  Neurochem Res       Date:  2020-01-27       Impact factor: 3.996

Review 2.  The emerging role of α-synuclein truncation in aggregation and disease.

Authors:  Zachary A Sorrentino; Benoit I Giasson
Journal:  J Biol Chem       Date:  2020-05-18       Impact factor: 5.157

Review 3.  Neuropathology and pathogenesis of extrapyramidal movement disorders: a critical update-I. Hypokinetic-rigid movement disorders.

Authors:  Kurt A Jellinger
Journal:  J Neural Transm (Vienna)       Date:  2019-06-18       Impact factor: 3.575

Review 4.  Convergent Molecular Pathways in Type 2 Diabetes Mellitus and Parkinson's Disease: Insights into Mechanisms and Pathological Consequences.

Authors:  Sandeep Xxxx; Mir Hilal Ahmad; Linchi Rani; Amal Chandra Mondal
Journal:  Mol Neurobiol       Date:  2022-05-16       Impact factor: 5.590

Review 5.  Innate and adaptive immune responses in Parkinson's disease.

Authors:  Aubrey M Schonhoff; Gregory P Williams; Zachary D Wallen; David G Standaert; Ashley S Harms
Journal:  Prog Brain Res       Date:  2019-12-05       Impact factor: 2.453

6.  Disruption of cellular proteostasis by H1N1 influenza A virus causes α-synuclein aggregation.

Authors:  Rita Marreiros; Andreas Müller-Schiffmann; Svenja V Trossbach; Ingrid Prikulis; Sebastian Hänsch; Stefanie Weidtkamp-Peters; Ana Raquel Moreira; Shriya Sahu; Irina Soloviev; Suganya Selvarajah; Vishwanath R Lingappa; Carsten Korth
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-09       Impact factor: 11.205

7.  Co-Transmission of Alpha-Synuclein and TPPP/p25 Inhibits Their Proteolytic Degradation in Human Cell Models.

Authors:  Attila Lehotzky; Judit Oláh; János Tibor Fekete; Tibor Szénási; Edit Szabó; Balázs Győrffy; György Várady; Judit Ovádi
Journal:  Front Mol Biosci       Date:  2021-05-18

Review 8.  Parkinson disease and the immune system - associations, mechanisms and therapeutics.

Authors:  Eng-King Tan; Yin-Xia Chao; Andrew West; Ling-Ling Chan; Werner Poewe; Joseph Jankovic
Journal:  Nat Rev Neurol       Date:  2020-04-24       Impact factor: 42.937

9.  LRP10 interacts with SORL1 in the intracellular vesicle trafficking pathway in non-neuronal brain cells and localises to Lewy bodies in Parkinson's disease and dementia with Lewy bodies.

Authors:  Martyna M Grochowska; Ana Carreras Mascaro; Valerie Boumeester; Domenico Natale; Guido J Breedveld; Hanneke Geut; Wiggert A van Cappellen; Agnita J W Boon; Anneke J A Kievit; Esther Sammler; Piero Parchi; Pietro Cortelli; Dario R Alessi; Wilma D J van de Berg; Vincenzo Bonifati; Wim Mandemakers
Journal:  Acta Neuropathol       Date:  2021-04-28       Impact factor: 17.088

Review 10.  Alpha-synuclein research: defining strategic moves in the battle against Parkinson's disease.

Authors:  Luis M A Oliveira; Thomas Gasser; Robert Edwards; Markus Zweckstetter; Ronald Melki; Leonidas Stefanis; Hilal A Lashuel; David Sulzer; Kostas Vekrellis; Glenda M Halliday; Julianna J Tomlinson; Michael Schlossmacher; Poul Henning Jensen; Julia Schulze-Hentrich; Olaf Riess; Warren D Hirst; Omar El-Agnaf; Brit Mollenhauer; Peter Lansbury; Tiago F Outeiro
Journal:  NPJ Parkinsons Dis       Date:  2021-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.